Amarin Corporation plc
2 Pembroke House
Upper Pembroke Street 28-32
Dublin,
2
Ireland - Map
Phone: 353 1 669 9020
Website: http://www.amarincorp.com
Amarin Corporation plc, a biopharmaceutical company, focuses on the development and commercialization therapeutic products for the treatment for cardiovascular diseases. Its product development program areas include lipid science and therapeutic benefits of polyunsaturated fatty acids. The company lead product comprises Vascepa, a prescription-only omega-3 fatty acid comprising icosapent ethyl as an adjunct to diet to reduce triglyceride levels in adult patients with severe hypertriglyceridemia. It also engages in developing Vascepa for the treatment of patients with high triglyceride levels who are also on statin therapy for elevated low-density lipoprotein cholesterol levels. The company was formerly known as Ethical Holdings plc. Amarin Corporation plc was founded in 1989 and is headquartered in Dublin, Ireland. Key Statistics
| |
| | Pay | Exercised | Mr. Joseph S. Zakrzewski ,
50
Exec. Chairman and Chief Exec. Officer | 855.00K | 7.04M | Mr. John F. Thero ,
52
Pres, Principal Financial Officer, Principal Accounting Officer and Assistant Sec. | 542.00K | 5.08M | Mr. Joseph T. Kennedy J.D.,
45
Chief Compliance Officer, Sr. VP, Gen. Counsel and Sec. | 547.00K | 34.00K | Dr. Paresh Soni ,
52
Head of Devel. and Sr. VP | 443.00K | 3.66M | Dr. Steven B. Ketchum Ph.D.,
48
Sr. VP and Pres of R&D | 471.00K | 0.00 |
|
| | Amounts are as of Dec 30, 2012 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year. | | Currency in USD. |
|
0.07(0.99%) May 21, 4:00PM EDT